Latest news
Is Johnson & Johnson (JNJ) Fully Valued On Darzalex Royalty Strength? - simplywall.stsimplywall.st · Fri, 07 Aug 2026 19:41:15 GMTGenmab's H1 Preview: Darzalex Beats The Sales Outlook - Seeking AlphaSeeking Alpha · Tue, 28 Jul 2026 07:00:00 GMTPhysician Views Results: Haematologists say Sarclisa's on-body injector likely to poke holes in Darzalex Faspro's dominance - FirstWord PHARMAFirstWord PHARMA · Mon, 27 Jul 2026 01:24:51 GMT